Invention Grant
- Patent Title: Lyophilized formulations of engineered anti-IL-23p19 antibodies
- Patent Title (中): 工程化抗IL-23p19抗体的冻干制剂
-
Application No.: US13061076Application Date: 2009-08-25
-
Publication No.: US08263748B2Publication Date: 2012-09-11
- Inventor: Xuhong Li , Ramesh S. Kashi , Aniket Badkar
- Applicant: Xuhong Li , Ramesh S. Kashi , Aniket Badkar
- Applicant Address: US NJ Rahway
- Assignee: Schering Corporation
- Current Assignee: Schering Corporation
- Current Assignee Address: US NJ Rahway
- Agent Gregory R. Bellomy
- International Application: PCT/US2009/054842 WO 20090825
- International Announcement: WO2010/027766 WO 20100311
- Main IPC: C07K16/00
- IPC: C07K16/00 ; A61K39/395
Abstract:
The present invention provides lyophilized formulations of antibodies, such as antibodies that specifically bind to human interleukin-23 p19 (IL-23p19), or antigen binding fragments thereof.
Public/Granted literature
- US20110229490A1 Lyophilized Formulations of Engineered Anti-IL-23p19 Antibodies Public/Granted day:2011-09-22
Information query
